BackDermata Therapeutics- Warrants (13/08/2026) Overview

Dermata Therapeutics- Warrants (13/08/2026) Operating Income

Operating Income for DRMAW.

Quarterly Operating Income

$-1926382.00
↓ 17.67% YoY

As of Mar 31, 2026

Annual Operating Income (TTM)

$-7360177.00
↓ 38.51% YoY

Trailing 12 months ending Mar 31, 2026

Average Operating Income (Comparison Companies)

Operating Income History

Operating Income Comparison

Annual Operating Income Growth Rate (%)

Annual Operating Income Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin